News Stories

Jun, 2020

Esperion has announced that NEXLIZET™ (bempedoic acid and ezetimibe) Is now available in pharmacies in the United States. NEXLIZET™ is an oral, once-daily, fixed-dose combination tablet indicated as an adjunct to diet and maximally tolerated statin for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH) or established atherosclerotic cardiovascular disease (ASCVD) who require additional lowering of LDL-C.

 

0
No votes yet
Name: Top Stories
Jun, 2020

0
No votes yet
Name: NLA News
May, 2020

Register for the NLA Annual Business Meeting by clicking here

Join us on Monday, June 8 from 6:00 – 6:30 PM ET for the NLA’s Annual Business Meeting for important NLA updates and award announcements:

0
No votes yet
Name: NLA News